Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
María-Jesús Lobón-IglesiasMamy AndrianteranagnaZhi-Yan HanCéline ChauvinJulien Masliah-PlanchonValeria ManriquezArnault Tauziede-EspariatSandrina TurczynskiRachida Bouarich-BourimiMagali FrahChristelle DufourThomas BlauwblommeLiesbeth CardoenGaëlle PierronLaetitia MaillotDelphine GuillemotStéphanie ReynaudChristine BourneixCélio PouponnotDidier SurdezMylène BohecSylvain BaulandeOlivier O DelattreEliane PiaggioOlivier AyraultJoshua J WaterfallNicolas ServantKevin BeccariaVolodia Dangouloff-RosFranck BourdeautPublished in: Nature communications (2023)
Atypical teratoid rhabdoid tumors (ATRT) are divided into MYC, TYR and SHH subgroups, suggesting diverse lineages of origin. Here, we investigate the imaging of human ATRT at diagnosis and the precise anatomic origin of brain tumors in the Rosa26-Cre ERT2 ::Smarcb1 flox/flox model. This cross-species analysis points to an extra-cerebral origin for MYC tumors. Additionally, we clearly distinguish SHH ATRT emerging from the cerebellar anterior lobe (CAL) from those emerging from the basal ganglia (BG) and intra-ventricular (IV) regions. Molecular characteristics point to the midbrain-hindbrain boundary as the origin of CAL SHH ATRT, and to the ganglionic eminence as the origin of BG/IV SHH ATRT. Single-cell RNA sequencing on SHH ATRT supports these hypotheses. Trajectory analyses suggest that SMARCB1 loss induces a de-differentiation process mediated by repressors of the neuronal program such as REST, ID and the NOTCH pathway.